Effectdossier · gearchiveerd kwartaal
TGTX
TG Therapeutics, Inc. · Healthcare · Biotechnology
15Gevolgde houders
0Δ houders
56.34MGehouden aandelen
$2.03BGerapporteerde waarde
+1Nieuwe posities
−1Uitstappen
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +5.2% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 117 | +11 | 84.53M | $4.64B | +13 | −2 |
| Q1 2026 | 109 | 0 | 78.24M | $2.60B | +7 | −7 |
| Q4 2025 | 108 | 0 | 85.68M | $2.55B | — | — |
| Q3 2025 | 18 | +1 | 56.55M | $2.04B | +1 | −1 |
| Q2 2025 | 15 | 0 | 56.34M | $2.03B | +1 | −1 |
| Q1 2025 | 12 | +2 | 14.38M | $567.04M | +2 | — |
| Q4 2024 | 10 | -1 | 14.56M | $438.37M | — | −1 |
| Q3 2024 | 10 | -3 | 5.57M | $130.22M | — | −3 |
| Q2 2024 | 13 | — | 11.93M | $212.32M | — | — |
Wie het bezit · Q2 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 21.81M | — | $785.06M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (passief) | 21.81M | — | $785.06M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (passief) | 21.81M | — | $785.06M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 21.81M | — | $785.06M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 21.81M | — | $785.06M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 21.81M | — | $785.06M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 21.81M | — | $785.06M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 21.81M | — | $785.06M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 21.81M | — | $785.06M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 21.81M | — | $785.06M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 21.81M | — | $785.06M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 21.81M | — | $785.06M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 21.81M | — | $785.06M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 21.81M | — | $785.06M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passief) | 21.81M | — | $785.06M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (passief) | 21.81M | — | $785.06M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (passief) | 21.81M | — | $785.06M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | The Vanguard Group ✦ (passief) | 15.81M | — | $568.98M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | The Vanguard Group ✦ (passief) | 15.81M | — | $568.98M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | The Vanguard Group ✦ (passief) | 15.81M | — | $568.98M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | The Vanguard Group ✦ (passief) | 15.81M | — | $568.98M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | The Vanguard Group ✦ (passief) | 15.81M | — | $568.98M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | State Street Global Advisors ✦ (passief) | 7.62M | +2.5% | $274.18M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 24 | Geode Capital Management ✦ (passief) | 3.49M | +6.3% | $126.03M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | Geode Capital Management ✦ (passief) | 3.49M | +6.3% | $126.03M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 26 | Fidelity (FMR) ✦ | 1.55M | — | $55.86M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Fidelity (FMR) ✦ | 1.55M | — | $55.86M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Fidelity (FMR) ✦ | 1.55M | — | $55.86M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | T. Rowe Price ✦ | 1.55M | +296.3% | $55.70M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | T. Rowe Price ✦ | 1.55M | +296.3% | $55.70M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 31 | Wellington Management ✦ | 1.23M | +1.4% | $44.25M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 32 | Wellington Management ✦ | 1.23M | +1.4% | $44.25M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 33 | Wellington Management ✦ | 1.23M | +1.4% | $44.25M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 34 | Wellington Management ✦ | 1.23M | +1.4% | $44.25M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 35 | Wellington Management ✦ | 1.23M | +1.4% | $44.25M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 36 | Wellington Management ✦ | 1.23M | +1.4% | $44.25M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 37 | Wellington Management ✦ | 1.23M | +1.4% | $44.25M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 38 | Citadel Advisors ✦ | 1.04M | +61.7% | $37.59M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 39 | Citadel Advisors ✦ | 1.04M | +61.7% | $37.59M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 40 | Point72 Asset Management ✦ | 717.51K | Nieuw | $25.82M | 0.1% | New | 1 | SEC ↗ |
| 41 | Millennium Management ✦ | 615.73K | +586.2% | $22.16M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 42 | Two Sigma Investments ✦ | 613.71K | -22.7% | $22.09M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 43 | D. E. Shaw & Co. ✦ | 118.14K | +90.8% | $4.25M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 44 | D. E. Shaw & Co. ✦ | 118.14K | +90.8% | $4.25M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 45 | Norges Bank ✦ (passief) | 89.82K | -58.9% | $3.23M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 46 | Gotham Asset Management ✦ | 45.33K | -3.0% | $1.63M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 47 | AQR Capital Management ✦ | 33.35K | -5.5% | $1.20M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 48 | AQR Capital Management ✦ | 33.35K | -5.5% | $1.20M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 49 | AQR Capital Management ✦ | 33.35K | -5.5% | $1.20M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 50 | AQR Capital Management ✦ | 33.35K | -5.5% | $1.20M | 0.0% | ▼ Trim | 5 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Point72 Asset Management | $25.82M | 0.1% |
Verlaten
| Renaissance Technologies | $6.65M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 359 houders, 105.22M aandelen, $3.44B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q2 2025 ·
Methodologie ·
Verkrijg dit via de API